As on 11-May-2023 09:30 EST
$0.14
$0.13
$0.16
$0.13
209,632
$0.09 - 1.20
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Titan Medical (TMDI)
| -78.02 | 22.65 | -39.54 | -70.98 | -16.59 | -52.25 | -37.59 |
S&P BSE Sensex*
| 8.77 | 3.75 | 1.98 | 6.23 | 14.44 | 13.26 | 12.48 |
#
| -- | -- | -- | -- | -- | -- | -- |
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
---|---|---|---|---|---|---|---|
Titan Medical (TMDI)
| 4.76 | -63.16 | 245.45 | -59.43 | -86.30 | 25.00 | -68.00 |
S&P BSE Sensex
| 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 | 1.95 |
S&P BSE Sensex
| 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 | 1.95 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Titan Medical Inc. (TMDI) stood at $ 28 Mln as on 30-Sep-22
The share price of Titan Medical Inc. (TMDI) is $0.15 (NASDAQ) as of 11-May-2023 09:30 EST. Titan Medical Inc. (TMDI) has given a return of -16.59% in the last 3 years.
Titan Medical Inc. (TMDI) has a market capitalisation of $ 16 Mln as on 31-May-2023. As per Value Research classification, it is a company.
The P/B ratio of Titan Medical Inc. (TMDI) is 11.57 times as on 31-May-2023, a 1.88% premium to its peers’ median range of 4.02 times.
Since, TTM earnings of Titan Medical Inc. (TMDI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Titan Medical Inc. (TMDI) and enter the required number of quantities and click on buy to purchase the shares of Titan Medical Inc. (TMDI).
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
The CEO & director of Mr. Cary G. Vance. is Titan Medical Inc. (TMDI), and CFO & Sr. VP is Mr. Stephen L. Lemieux BA, CA, CPA, MMPA.
The promoters of Titan Medical Inc. (TMDI) have pledged 0% of the total equity as on Dec-22.
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
334
|
|
252
|
|
71
|
|
62
|
Titan Medical Inc. (TMDI) | Ratios |
---|---|
Return on equity(%)
|
-21.18
|
Return on capital employed(%)
|
--
|
Debt-to-equity ratio
|
0
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Titan Medical Inc. (TMDI) was $-21 Mln.
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access... surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada. Read more
Sign up and get access to:
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.